AOD-9604: Best Telehealth Providers for Weight Loss Management (2026)
A modified fragment (amino acids 176-191) of human growth hormone designed to stimulate fat metabolism without the growth-promoting effects of full HGH. Studied as a targeted fat-loss peptide.
AOD-9604 at a Glance
Category
Weight Loss Management
Administration
Subcutaneous injection
Telehealth Providers
4 compared
Price Range
$150 – $220/mo
Typical Dose
250-500mcg
Frequency
Once daily
Protocol Duration
12-20 weeks
Prescription
Required
Research highlight: AOD-9604 received FDA GRAS (Generally Recognized as Safe) status as a food ingredient in 2014, validating its safety profile as a lipolytic HGH fragment that targets fat loss without activating IGF-1 or insulin-like growth effects.
What is AOD-9604 Used For?
Also known as: Anti-Obesity Drug 9604
- Fat metabolism
- Body composition
- Weight management
How AOD-9604 Works
AOD-9604 is a modified fragment of human growth hormone (amino acids 176–191, the lipolytic domain) with an added tyrosine residue at its N-terminus for stability. It activates the same beta-3 adrenergic receptors as the lipolytic portion of full HGH, stimulating fat cell breakdown (lipolysis) and inhibiting new fat cell formation (lipogenesis). Crucially, it does so without activating the IGF-1 receptor or insulin-like growth effects, making it metabolically safer than full HGH for fat-targeting purposes.
AOD-9604Dosing & Administration
| Typical Dose | 250-500mcg |
| Frequency | Once daily |
| Protocol Duration | 12-20 weeks |
| Route | Subcutaneous injection |
Dosing information is for educational purposes only. Your prescribing physician will determine the appropriate dose based on your medical history and treatment goals.
What to Expect from AOD-9604
Reduced subcutaneous fat — particularly in abdominal and visceral areas — is the primary goal. Most protocols run 12–20 weeks, with meaningful changes in body composition typically visible at 8–12 weeks. Results are dose-dependent and work best in conjunction with a moderate caloric deficit and resistance training. AOD-9604 is not a replacement for GLP-1 medications in terms of scale of weight loss.
Who Should Consider AOD-9604?
- Targeted fat loss in already-lean individuals
- Body recomposition without GH-related side effects
- Those seeking fat loss without appetite suppression effects
- Patients who want to avoid IGF-1 elevation from full GH therapy
AOD-9604 Side Effects
- Generally very well-tolerated in clinical trials
- Mild injection site redness
- Headache (uncommon)
- Nausea (rare)
This is not a complete list of side effects. Always consult your prescribing physician before starting AOD-9604.
4 Telehealth Providers Offering AOD-9604
Sorted by lowest price. All providers require a prescription from a licensed physician.
| Provider | Price | Dose | Rating | Consultation | Lab Testing |
|---|---|---|---|---|---|
| Heally San Francisco, CA | $150/monthly | 300mcg/day | 3.9/5 | Video Telehealth | Not included |
| Defy Medical Tampa, FL | $160/monthly | 300mcg/day | 4.1/5 | Video Telehealth | Included |
| Evolve Telemed San Diego, CA | $185/monthly | 300mcg/day | 4.0/5 | Video Telehealth | Included |
| TruLife Health Scottsdale, AZ | $220/monthly | 300mcg/day | 4.1/5 | Video Telehealth | Included |
How to Choose the Best Telehealth Provider for Weight Loss Management
Not all online weight-loss programs are equal. These are the criteria we evaluate when ranking telehealth providers for weight loss medications.
Licensed Medical Supervision
The best providers require a licensed physician or NP to review your health history and approve your prescription — not just an intake algorithm. Asynchronous intake is fine; skipping real medical review is not.
Transparent Per-Dose Pricing
Weight loss programs range from $99 to $500+/month for semaglutide. Look for providers that clearly state the dose included and cost per mg so you can compare programs on equal terms.
Compounding Pharmacy Quality
Compounded medications must come from an FDA-registered 503A or 503B pharmacy. Ask which pharmacy your provider uses and verify its accreditation — sterility and potency standards vary significantly.
Proper Dose Titration
GLP-1 medications should start at a low dose and escalate gradually over weeks. Providers who skip titration to speed results are prioritizing revenue over your safety.
Lab Monitoring
Baseline labs (metabolic panel, HbA1c, lipids) and periodic follow-up are standard of care for GLP-1 therapy. Providers who require or include labs are practicing at a higher standard.
Long-Term Support
Weight management is a long-term commitment. Look for providers with clear refill processes, messaging access to your care team, and supply chain stability beyond the promotional first month.
Frequently Asked Questions About AOD-9604
Is AOD-9604 as effective for weight loss as semaglutide?
No — AOD-9604 produces modest fat loss compared to GLP-1 agonists like semaglutide or tirzepatide. Its mechanism is specifically lipolytic (fat cell breakdown) rather than appetite-suppressing. It is typically chosen for targeted body recomposition in already-lean individuals rather than significant weight reduction in obese patients.
Does AOD-9604 affect blood sugar?
AOD-9604 was specifically designed to separate the lipolytic effects of HGH from its metabolic effects on insulin. Clinical studies show minimal impact on blood glucose, insulin levels, or IGF-1 — making it metabolically safer than full HGH for long-term use in non-diabetic individuals.
Can AOD-9604 be stacked with other peptides?
Yes. Common stacks include AOD-9604 with CJC-1295/Ipamorelin (for muscle growth alongside fat loss) or with semaglutide (for amplified fat-loss effects through complementary mechanisms). Always discuss stacking intentions with your prescribing physician.
Is AOD-9604 FDA-approved?
AOD-9604 received FDA GRAS (Generally Recognized as Safe) status as a food ingredient in 2014 and was studied in Phase 2 obesity trials. However, it did not advance to FDA drug approval. It is currently available through compounding pharmacies under physician prescription.
Related Guides
- GLP-1 and Muscle Loss: What Patients Need to Know
- GLP-1 Friendly Diet: What to Eat on Semaglutide, Tirzepatide & Other GLP-1s
- How to Start GLP-1 Treatment: Complete 7-Step Process Guide
- GLP-1 Weight Loss Plateau: Why It Happens and What to Do About It
- How to Calculate True GLP-1 Costs: Complete Methodology Guide 2026
AOD-9604 Alternatives for Weight Loss Management
Compare other weight loss management peptides available through telehealth.
Liraglutide
A GLP-1 receptor agonist administered daily for chronic weight management. FDA-approved as Saxenda for obesity and as Victoza for type 2 diabetes. One of the first GLP-1 medications widely used for weight loss before semaglutide.
Retatrutide
A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 3 clinical trials show weight loss exceeding tirzepatide, positioning it as the most potent anti-obesity peptide in development.
Semaglutide
A GLP-1 receptor agonist originally developed for type 2 diabetes, now widely prescribed for weight management. Reduces appetite and slows gastric emptying.
Tirzepatide
A dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes. Clinical trials show significant weight reduction, often exceeding semaglutide results.